Literature DB >> 32514746

Heat-Killed Lactobacillus reuteri GMNL-263 Inhibits Systemic Lupus Erythematosus-Induced Cardiomyopathy in NZB/W F1 Mice.

Peng Xiang1, Chih-Yang Huang2,3,4,5, Yu-Lan Yeh6,7, Min-Chi Lu8,9, Bruce Chi-Kang Tsai10, Bor-Show Tzang11, Shiu-Min Cheng12, Xiaoyong Zhang13, Liang-Yo Yang14, B Mahalakshmi15, Wei-Wen Kuo16.   

Abstract

It has been increasingly recognized that accelerated atherosclerosis is a major cause of morbidity and mortality in patients with systemic lupus erythematosus, a multisystem autoimmune disease. In this study, we investigated the anti-apoptotic effects of heat-killed Lactobacillus reuteri GMNL-263 on the cardiac tissue of NZB/W F1 mice. The myocardial architecture of the mice heart was observed and evaluated using different staining techniques such as hematoxylin and eosin, TUNEL assay, Masson's trichrome, and fluorescent immunohistochemistry. Additionally, the probiotics-related pathway proteins were analyzed via western blot analysis. Our results showed prevention of enlarged interstitial spaces and abnormal myocardial structures in the hearts of NZB/W F1 mice with L. reuteri GMNL-263 feeding. Significant reduction in TUNEL-positive cells, Fas death receptor-related components, and apoptosis was also detected in the cardiac tissues of the NZB/W F1 mice after L. reuteri GMNL-263 feeding compared with the control group. These findings are the first to reveal the protective effects of L. reuteri GMNL-263 against cardiac abnormalities in NZB/W F1 mice and suggest the potential clinical applications of L. reuteri GMNL-263 in the treatment of SLE-related cardiovascular diseases.

Entities:  

Keywords:  Atherosclerosis; Cardiomyopathy; Lactobacillus reuteri GMNL-263; Probiotic bacteria; Systemic lupus erythematosus

Mesh:

Year:  2021        PMID: 32514746     DOI: 10.1007/s12602-020-09668-1

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  24 in total

1.  Heat-killed and live Lactobacillus reuteri GMNL-263 exhibit similar effects on improving metabolic functions in high-fat diet-induced obese rats.

Authors:  Feng-Ching Hsieh; Cheng-Che E Lan; Tsui-Yin Huang; Kuan-Wei Chen; Chee-Yin Chai; Wan-Tzu Chen; Ai-Hui Fang; Yi-Hsing Chen; Ching-Shuang Wu
Journal:  Food Funct       Date:  2016-05-10       Impact factor: 5.396

2.  Effects of supervised cardiovascular training program on exercise tolerance, aerobic capacity, and quality of life in patients with systemic lupus erythematosus.

Authors:  Maria Rosenilda P de Carvalho; Emilia I Sato; Antonio S Tebexreni; Raquel T C Heidecher; Simone Schenkman; Turíbio L Barros Neto
Journal:  Arthritis Rheum       Date:  2005-12-15

3.  Probiotic therapy with Saccharomyces boulardii for heart failure patients: a randomized, double-blind, placebo-controlled pilot trial.

Authors:  Annelise C Costanza; Samuel D Moscavitch; Hugo C C Faria Neto; Evandro T Mesquita
Journal:  Int J Cardiol       Date:  2014-11-11       Impact factor: 4.164

Review 4.  Role of probiotics and functional foods in health: gut immune stimulation by two probiotic strains and a potential probiotic yoghurt.

Authors:  Carolina Maldonado Galdeano; Ivanna Novotny Nuñez; Esteban Carmuega; Alejandra de Moreno de LeBlanc; Gabriela Perdigón
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2015       Impact factor: 2.895

Review 5.  Atherosclerosis in systemic lupus erythematosus.

Authors:  Sara Croca; Anisur Rahman
Journal:  Best Pract Res Clin Rheumatol       Date:  2017-10-16       Impact factor: 4.098

6.  Effects of oral Lactobacillus administration on antioxidant activities and CD4+CD25+forkhead box P3 (FoxP3)+ T cells in NZB/W F1 mice.

Authors:  Bor-Show Tzang; Chung-Hsien Liu; Kuo-Ching Hsu; Yi-Hsing Chen; Chih-Yang Huang; Tsai-Ching Hsu
Journal:  Br J Nutr       Date:  2017-09       Impact factor: 3.718

7.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus.

Authors:  M Petri; S Perez-Gutthann; D Spence; M C Hochberg
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

8.  Risk factors for subclinical atherosclerosis in a prospective cohort of patients with systemic lupus erythematosus.

Authors:  A Doria; Y Shoenfeld; R Wu; P F Gambari; M Puato; A Ghirardello; B Gilburd; S Corbanese; M Patnaik; S Zampieri; J B Peter; E Favaretto; L Iaccarino; Y Sherer; S Todesco; P Pauletto
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

9.  Lactobacillus paracasei GMNL-32 exerts a therapeutic effect on cardiac abnormalities in NZB/W F1 mice.

Authors:  Wei-Syun Hu; Peramaiyan Rajendran; Bor-Show Tzang; Yu-Lan Yeh; Chia-Yao Shen; Ray-Jade Chen; Tsung-Jung Ho; Viswanadha Vijaya Padma; Yi-Hsing Chen; Chih-Yang Huang
Journal:  PLoS One       Date:  2017-09-21       Impact factor: 3.240

10.  Heat-killed Lactobacillus Reuteri GMNL-263 Prevents Epididymal Fat Accumulation and Cardiac Injury in High-Calorie Diet-Fed Rats.

Authors:  Po-Hsiang Liao; Wei-Wen Kuo; Dennis Jine-Yuan Hsieh; Yu-Lan Yeh; Cecilia-Hsuan Day; Ya-Hui Chen; Sheng-Huang Chang; V Vijaya Padma; Yi-Hsing Chen; Chih-Yang Huang
Journal:  Int J Med Sci       Date:  2016-07-05       Impact factor: 3.738

View more
  2 in total

Review 1.  Lactobacillus: Friend or Foe for Systemic Lupus Erythematosus?

Authors:  Weijie Wang; Yongsheng Fan; Xinchang Wang
Journal:  Front Immunol       Date:  2022-05-23       Impact factor: 8.786

Review 2.  Immune Privilege: The Microbiome and Uveitis.

Authors:  Christine Mölzer; Jarmila Heissigerova; Heather M Wilson; Lucia Kuffova; John V Forrester
Journal:  Front Immunol       Date:  2021-01-25       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.